Showing results (141-150 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Current Developments in Nutrition|May 14, 2023
Supplemental wheat germ modulates phosphorylation of STAT3 in the gut and NF-κBp65 in the adipose tissue of mice fed a Western dietBabajide A Ojo, Sanmi E Alake, Amritpal Kaur, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2011
Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesotheliomaSteven Chuan-Hao Kao, Tristan D Yan, Kenneth Lee, et al.
Pathology|January 15, 2011
Validation of tissue microarray technology in malignant pleural mesotheliomaSteven C H Kao, Kenneth Lee, Nicola J Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification of distinctive protein expression patterns in colorectal adenomaFrancis F Lam, Lucy Jankova, Owen F Dent, et al.
Clinical Lung Cancer|June 15, 2021
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung CancerJose Luis Leal, Marliese Alexander, Malinda Itchins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2023
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.
The American Journal of Surgical Pathology|October 19, 2020
A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel ApproachAngela Chou, Mahsa Ahadi, Jennifer Arena, et al.
Frontiers in Oncology|March 21, 2020
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant ChemotherapySumit Sahni, Christopher Nahm, Christoph Krisp, et al.
Pageof 20